Status:
UNKNOWN
Cost-effectiveness Analysis Between Two Anticoagulation Strategies for Atrial Fibrillation in the Postoperative Period of Coronary Artery Bypass Graft Surgery
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
Atrial Fibrillation New Onset
Eligibility:
All Genders
18-100 years
Phase:
PHASE4
Brief Summary
Coronary artery bypass graft (CABG) surgery is a common intervention in patients with coronary artery disease (CAD). The presence of new postoperative atrial fibrillation / atrial flutter (POAF) occur...
Eligibility Criteria
Inclusion
- New atrial/flutter fibrillation / flutter lasting more than 12 hours in the postoperative period of CABG
- Individuals in both sex over the age of 18 years
Exclusion
- Inability to sign the free and informed consent form
- Contraindication to anticoagulant therapy
- Renal dysfunction with eGFR less than 30ml / min / 1.73m² or dialysis therapy
- Patients with previous AF
- Pregnancy
- Concomitant valve surgery
Key Trial Info
Start Date :
January 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05300555
Start Date
January 5 2021
End Date
November 1 2022
Last Update
March 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Heart Institute - University of São Paulo
São Paulo, São Paulo, Brazil, 05403000